Open Label Study to Evaluate Safety and Efficacy of LUM001 in Patients With Primary Sclerosing Cholangitis
Clinical trial NCT02061540 · COMPLETED
Trial details
- NCT number
- NCT02061540
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2016-02-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.